Captopril Oral Solution
» Captopril Oral Solution contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of captopril (C9H15NO3S). Prepare Captopril Oral Solution 0.75 mg per mL as follows (see Pharmaceutical Compounding—Nonsterile Preparations 
795
. See also Captopril Oral Suspension):
795. See also Captopril Oral Suspension): | Captopril powder | 75 mg |
| Vehicle for Oral Solution (regular or sugar-free), NF, a sufficient quantity | |
 to make |
100 mL |
Add Captopril powder and about 10 mL of Vehicle to a mortar, and mix. Add the Vehicle in small portions almost to volume, and mix thoroughly after each addition. Transfer the contents of the mortar, stepwise and quantitatively, to a calibrated bottle. Add enough Vehicle to bring to final volume, and mix well.
Packaging and storage—
Preserve in tight, light-resistant containers. Store in a cold place.
Labeling—
Label it to state the beyond-use date.
USP Reference standards 11—
11—
USP Captopril RS 
') + '&img=../../images/v35300/cas-62571-86-2.gif',600,500);)
pH 791:
between 3.8 and 4.3.
791:
between 3.8 and 4.3.
Beyond-use date:
7 days after the day on which it was compounded.
Assay—
Mobile phase—
Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid. Make adjustments if necessary (see System Suitability under Chromatography 621).
621).
Standard preparation—
Dissolve USP Captopril RS in water to obtain a solution having a known concentration of 7.5 µg per mL.
Assay preparation—
Agitate the container of Oral Solution for 30 minutes on a rotating mixer, remove a 5-mL sample, and store in a clear glass vial at –70
until analyzed. At the time of analysis, remove the sample from the freezer, allow it to reach room temperature, and mix with a vortex mixer for 30 seconds. Pipet 1.0 mL of the sample into a 100-mL volumetric flask, and dilute with Mobile phase to volume.
until analyzed. At the time of analysis, remove the sample from the freezer, allow it to reach room temperature, and mix with a vortex mixer for 30 seconds. Pipet 1.0 mL of the sample into a 100-mL volumetric flask, and dilute with Mobile phase to volume.
Chromatographic system (see Chromatography 621)—
The liquid chromatograph is equipped with a 220-nm detector and a 4.6-mm × 25-cm analytical column that contains 5-µm packing L1. The flow rate is about 1 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the retention time is about 5.0 minutes; and the relative standard deviation for replicate injections is not more than 0.9%.
621)—
The liquid chromatograph is equipped with a 220-nm detector and a 4.6-mm × 25-cm analytical column that contains 5-µm packing L1. The flow rate is about 1 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the retention time is about 5.0 minutes; and the relative standard deviation for replicate injections is not more than 0.9%.
Procedure—
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of captopril (C9H15NO3S) in the volume of Oral Solution taken by the formula:
100(C / V)(rU / rS)
in which C is the concentration, in µg per mL, of USP Captopril RS in the Standard preparation; V is the volume, in mL, of Oral Solution taken; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
|---|---|---|
| Monograph | Jeanne H. Sun
Assistant Scientific Liaison 1-301-816-3361 |
(CMP2010) Compounding |
| Reference Standards | RS Technical Services 1-301-816-8129 rstech@usp.org |
USP35–NF30 Page 2477
Pharmacopeial Forum: Volume No. 32(1) Page 63